Irisin, bridging the gaps between exercise and cardiovascular health: A ray of hope
Linking exercise and cardiovascular health
DOI:
https://doi.org/10.52442/jrmi.v11i1.883Keywords:
BALB/c Mice, Dyslipidemia, Irisin, NicotineAbstract
Introduction: Irisin, an adipomyokine, is released in response to exercise from skeletal muscle and adipose tissue. Research has shown that exercise–induced release of myokines improves metabolic balance and enhances energy expenditure suggesting that irisin may play a role in the link between exercise and specific health benefits, particularly in cardiovascular and metabolic diseases.
Objective: To evaluate the role of r-irisin in improving nicotine-induced dyslipidemia by measuring serum lipids levels in BALB/c mice after parenteral administration of r-irisin.
Materials and Methods: An experimental animal study was conducted at Foundation University Islamabad in collaboration with the National Institute of Health, Islamabad. Three sets of thirty healthy BALB/c mice were housed under regular conditions. Group 1 (control group) was given normal saline intraperitoneally for 28 days. In Group 2 and 3, dyslipidemia was induced by administration of nicotine intraperitoneally for 28 days. In Group 3, in addition to nicotine, r-irisin was administered via tail vein injection for the last 14 days. On the 29th day, all mice were euthanized and intracardiac blood samples were taken for estimation of serum lipids levels. Statistical analysis was performed using SPSS version 24 with one-way ANOVA (to calculate differences across groups) and post-hoc Tukey’s test (for multiple comparisons among groups). A p-value of < 0.05 was considered as statistically significant.
Results: Group 2 showed a statistically significant increase in serum lipid levels (p<0.001) as compared to group 1. In Group 3, with co-administration of r-irisin, significant improvement in serum lipid levels was observed (p< 0.001) as compared to Group 2.
Conclusion: Exogenous administration of irisin improved serum dyslipidemia in BALB/c mice.
References
Myszko M, Bychowski J, Skrzydlewska E, Łuczaj W. The dual role of oxidative stress in atherosclerosis and Coronary Artery Disease: Pathological mechanisms and diagnostic potential. Antioxidants. 2025;14(3):275. doi: 10.3390/antiox14030275
Boieriu AM, Luca CD, Neculoiu CD, Bisoc A, Țînț D. Endothelial dysfunction and oxidative stress in patients with severe coronary artery disease: Does diabetes play a contributing role? Medicina. 2025;61(1):135. doi: 10.3390/medicina61010135.
Ren QW, Teng THK, Ouwerkerk W, Tse YK, Tsang CTW, Wu MZ, et al. Triglyceride levels and its association with all-cause mortality and cardiovascular outcomes among patients with heart failure. Nat Commun. 2025;16(1):1408. doi: 10.1038/s41467-025-56790-1.
Zhang Z, Guo J. Deciphering oxidative stress in cardiovascular disease progression: A blueprint for mechanistic understanding and therapeutic innovation. Antioxidants. 2024;14(1):38. doi: 10.3390/antiox14010038.
Imlay JA. Pathways of oxidative damage. Annu Rev Microbiol. 2003;57:395-418. doi: 10.1146/annurev.micro.57.030502.090938
Zhang S, Day I, Ye S. Nicotine induced changes in gene expression by human coronary artery endothelial cells. Atherosclerosis. 2001;154(2):277-83. doi:10.1016/s0021-9150(00)00475-5
Chakkarwar VA. Fenofibrate attenuates nicotine-induced vascular endothelial dysfunction in the rat. Vascul Pharmacol. 2011;55(5-6):163-8. doi: 10.1016/j.vph.2011.08.215.
Waseem R, Shamsi A, Mohammad T, Hassan MI, Kazim SN, Chaudhary AA, et al. FNDC5/Irisin: Physiology and Pathophysiology. Molecules. 2022;27(3):118. doi: 10.3390/molecules27031118.
Cosio PL, Peláez M, Cadefau JA, Farran-Codina A. Systematic Review and Meta-Analysis of circulating Irisin levels following Endurance Training: Results of Continuous and Interval Training. Biol Res Nurs. 2022;25(3):367- 81. doi: 10.1177/10998004221142580.
Rahimi G, Hejazi K, Hofmeister M. The effect of exercise interventions on Irisin level: a systematic review and meta-analysis of randomized controlled trials. EXCLI J. 2022;21: 524-39. doi: 10.17179/excli2022-4703.
Torabi A, Reisi J, Kargarfard M, Mansourian M. Differences in the impact of various types of exercise on Irisin Levels: A Systematic Review and Meta-Analysis. Int J Prev Med. 2024;15:11. doi: 10.4103/ijpvm.ijpvm_76_23.
Maalouf G-E, El Khoury D. Exercise‐Induced Irisin, the fat browning myokine, as a potential anticancer agent. J Obes. 2019;2019:6561726. doi: 10.1155/2019/6561726.
Hubrecht RC, Kirkwood J. The UFAW handbook on the care and management of laboratory and other research animals: John Wiley & Sons; 2010. www.wiley.com/go/ufaw. doi:10.1002/9781444318777
Si LY-N, Kamisah Y, Ramalingam A, Lim YC, Budin SB, Zainalabidin S. Roselle supplementation prevents nicotine-induced vascular eothelial dysfunction and remodelling in rats. Appl Physiol Nutr Metab. 2017;42(7):765-72. doi: 10.1139/apnm-2016-0506
Zhang Y, Song H, Zhang Y, Wu F, Mu Q, Jiang M, et al. Irisin inhibits atherosclerosis by promoting endothelial proliferation through microRNA126-5p. J Am Heart Assoc. 2016;5(9): e004031. doi: 10.1161/JAHA.116.004031.
Zhang Y, Mu Q, Zhou Z, Song H, Zhang Y, Wu F, et al. Protective effect of Irisin on atherosclerosis via suppressing oxidized Low Density Lipoprotein induced vascular inflammation and endothelial dysfunction. PLoS One. 2016;11(6):e0158038. doi: 10.1371/journal.pone.0158038.
Arhire LI, Mihalache L, Covasa M. Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome. Front Endocrinol (Lausanne). 2019;10:524. doi: 10.3389/fendo.2019.00524.
Wang Y, Yang Y, Song Y. Cardioprotective effects of exercise: The role of Irisin and exosome.. Curr Vasc Pharmacol. 2024;22(5):316-34. doi: 10.2174/0115701611285736240516101803.
de Oliveira M, Mathias LS, Rodrigues BM, Mariani BG, Graceli JB, De Sibio MT, et al. The roles of triiodothyronine and irisin in improving the lipid profile and directing the browning of human adipose subcutaneous cells. Mol Cell Endocrinol. 2020;506:110744. doi: 10.1016/j.mce.2020.110744.
Xiong X-Q, Chen D, Sun H-J, Ding L, Wang J-J, Chen Q, et al. FNDC5 overexpression and irisin ameliorate glucose/lipid metabolic derangements and enhance lipolysis in obesity. Biochim Biophy Acta. 2015;1852(9):1867-75. doi: 10.1016/j.bbadis.2015.06.017.
Oelmann S, Nauck M, Volzke H, Bahls M, Friedrich N. Circulating Irisin concentrations are associated with a favourable lipid profile in the general population. PLoS One. 2016;11(4):e0154319. doi: 10.1371/journal.pone.0154319. eCollection 2016.
Mehrabian S, Taheri E, Karkhaneh M, Qorbani M, Hosseini S. Association of circulating irisin levels with normal weight obesity, glycemic and lipid profile. J Diabetes Metab Disord. 2016;15:17. doi: 10.1186/s40200-016-0239-5.
Fang P, She Y, Yu M, Min W, Shang W, Zhang Z. Adipose–Muscle crosstalk in age-related metabolic disorders: The emerging roles of adipo-myokines. Ageing Res Rev. 2023; 84:101829. doi: 10.1016/j.arr.2022.101829.
